Spontaneous Extradural Hematoma in a Sickle Cell Anemia Patient with Hyperinflammation and Thrombotic Microangiopathy Successfully Treated with Eculizumab: A Case Report and Review of the Literature
Journal of Neurological Surgery Part A: Central European Neurosurgery · 01.11.2024 · 85 (06) · 625-632
DOI: 10.1055/a-2271-8772 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Neurological Surgery Part A: Central European Neurosurgery, erschienen am 01.11.2024. Verfasst von Michael Itak Ita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Antibodies, Monoclonal, Humanized, Thrombotic Microangiopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Background
The event of extradural hematoma in the absence of head trauma is a rare central nervous system complication of sickle cell disease. We report here a case of spontaneous extradural hematoma in a patient being treated for sickle cell vasoocclusive crisis complicated by hyperinflammation and thrombotic microangiopathy. The significance of inflammation as an integral component of the pathomechanism of vasoocclusive crisis in patients with sickle cell disease and the role of heme in activating the complement system's alternative pathway are highlighted in this case report. Case Presentation A teenage patient with sickle cell disease developed a spontaneous right parietal extradural hematoma while receiving treatment for sickle cell vasoocclusive crisis. The concurrent events of hyperinflammation, disseminated intravascular coagulation, hyperhemolysis syndrome, thrombotic microangiopathy, and refractory postoperative bleeding complicated this patient's clinical course after surgical evacuation of extradural hematoma. This patient was subsequently treated with eculizumab and improved in the days following.
Conclusion
Treatment with the anti-C5 monoclonal antibody eculizumab, which targets and inhibits terminal complement system activation, reversed the deleterious cascade of events in this patient with sickle cell disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
ORCID-Profile: Michael Itak Ita
Zitieren
APA
Ita, M. I., Olesen, P., Rosing, M., Mørk, M., Einarsson, H. B., & Riis, J. J. (2024). Spontaneous Extradural Hematoma in a Sickle Cell Anemia Patient with Hyperinflammation and Thrombotic Microangiopathy Successfully Treated with Eculizumab: A Case Report and Review of the Literature. Journal of Neurological Surgery Part A: Central European Neurosurgery, 85(06), 625-632. https://doi.org/10.1055/a-2271-8772
Vancouver
Ita MI, Olesen P, Rosing M, Mørk M, Einarsson HB, Riis JJ. Spontaneous Extradural Hematoma in a Sickle Cell Anemia Patient with Hyperinflammation and Thrombotic Microangiopathy Successfully Treated with Eculizumab: A Case Report and Review of the Literature. Journal of Neurological Surgery Part A: Central European Neurosurgery. 2024;85(06):625-632. doi:10.1055/a-2271-8772
BibTeX
@article{Ita2024,
author = {Ita, Michael Itak and Olesen, Pia and Rosing, Maria and Mørk, Morten and Einarsson, Halldór Bjarki and Riis, Jens Jakob},
title = {Spontaneous Extradural Hematoma in a Sickle Cell Anemia Patient with Hyperinflammation and Thrombotic Microangiopathy Successfully Treated with Eculizumab: A Case Report and Review of the Literature},
journal = {Journal of Neurological Surgery Part A: Central European Neurosurgery},
year = {2024},
volume = {85},
number = {06},
pages = {625--632},
doi = {10.1055/a-2271-8772}
}
EUVIMED